Literature DB >> 27019523

Coagulation factors in whole blood collected from pregnant women and stored at 4°C.

Miki Minatoguchi1, Atsuo Itakura2, Akinori Miki1, Takeshi Kajihara1, Shiho Sasaki3, Yumiko Takase3, Kiyoko Kobayashi4, Rumiko Asada4, Kenji Ikebuchi5, Osamu Ishihara1.   

Abstract

The present study aimed to measure the levels of coagulation factors in stored whole blood of pregnant women and to determine their usefulness in treating pregnant women who developed coagulopathy. A prospective study to measure coagulation factors in stored donated whole blood from pregnant and non-pregnant women was conducted. Fibrinogen, FV, FVII, FVIII, FXIII, and von Willebrand factor were measured in blood stored at 4°C for 0, 1, 3, and 5 weeks. All coagulation factors except for factor XIII decreased during storage. Fibrinogen and factor VII in the blood collected from pregnant women gradually decreased over time and their levels were significantly higher after 5 weeks of storage than those of non-pregnant women at week 0. Whole blood donated by pregnant women for autologous blood transfusion and stored at 4°C may be expected being effectively for the prevention of coagulopathy and the treatment of circulatory blood volume loss.

Entities:  

Keywords:  autologous blood transfusion; coagulopathy; fibrinogen; obstetric hemorrhage; whole blood

Mesh:

Substances:

Year:  2016        PMID: 27019523      PMCID: PMC4767509     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  16 in total

1.  Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A.

Authors:  Alessandro Malara; Cristian Gruppi; Paola Rebuzzini; Livia Visai; Cesare Perotti; Remigio Moratti; Cesare Balduini; Maria Enrica Tira; Alessandra Balduini
Journal:  Blood       Date:  2010-12-03       Impact factor: 22.113

Review 2.  Obstetric hemorrhage.

Authors:  C McLintock; A H James
Journal:  J Thromb Haemost       Date:  2011-08       Impact factor: 5.824

Review 3.  Blood product replacement for postpartum hemorrhage.

Authors:  Andrea J Fuller; Brenda A Bucklin
Journal:  Clin Obstet Gynecol       Date:  2010-03       Impact factor: 2.190

4.  Fibrinogen concentrate substitution therapy for obstetric hemorrhage complicated by coagulopathy.

Authors:  Mariko Kikuchi; Atsuo Itakura; Akinori Miki; Manabu Nishibayashi; Kenji Ikebuchi; Osamu Ishihara
Journal:  J Obstet Gynaecol Res       Date:  2012-12-21       Impact factor: 1.730

5.  Changes in haemostasis during normal pregnancy.

Authors:  Ekaterina H Uchikova; Ilija I Ledjev
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-04-01       Impact factor: 2.435

Review 6.  Cell salvage as part of a blood conservation strategy in anaesthesia.

Authors:  A Ashworth; A A Klein
Journal:  Br J Anaesth       Date:  2010-08-28       Impact factor: 9.166

7.  New insights into the expression and role of platelet factor XIII-A.

Authors:  A Jayo; I Conde; P Lastres; V Jiménez-Yuste; C González-Manchón
Journal:  J Thromb Haemost       Date:  2009-04-24       Impact factor: 5.824

8.  Postpartum hemorrhage management in 2012: predicting the future.

Authors:  Oluwatoyosi Onwuemene; David Green; Louis Keith
Journal:  Int J Gynaecol Obstet       Date:  2012-08-04       Impact factor: 3.561

Review 9.  Transfusion medicine in obstetrics and gynecology.

Authors:  J T Santoso; D W Lin; D S Miller
Journal:  Obstet Gynecol Surv       Date:  1995-06       Impact factor: 2.347

10.  Whole blood in the management of hypovolemia due to obstetric hemorrhage.

Authors:  James M Alexander; Ravindra Sarode; Donald D McIntire; James D Burner; Kenneth J Leveno
Journal:  Obstet Gynecol       Date:  2009-06       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.